EYEN Eyenovia, Inc. Stock Quote

EYEN [NASD]

Index	-	P/E	-	EPS (ttm)	-0.97	Insider Own	20.40%	Shs Outstand	24.81M	Perf Week	-4.35%
Market Cap	140.91M	Forward P/E	-	EPS next Y	-0.70	Insider Trans	0.75%	Shs Float	15.61M	Perf Month	-8.94%
Income	-19.80M	PEG	-	EPS next Q	-0.22	Inst Own	7.70%	Short Float	0.84%	Perf Quarter	-20.98%
Sales	2.00M	P/S	70.45	EPS this Y	36.30%	Inst Trans	9.67%	Short Ratio	0.93	Perf Half Y	62.24%
Book/sh	0.62	P/B	8.87	EPS next Y	16.70%	ROA	-91.90%	Target Price	-	Perf Year	102.95%
Cash/sh	1.11	P/C	4.96	EPS next 5Y	-	ROE	-144.80%	52W Range	2.55 - 7.72	Perf YTD	-9.24%
Dividend	-	P/FCF	-	EPS past 5Y	-16.90%	ROI	-125.20%	52W High	-28.76%	Beta	-
Dividend %	-	Quick Ratio	1.80	Sales past 5Y	-	Gross Margin	60.00%	52W Low	115.68%	ATR	0.41
Employees	31	Current Ratio	1.80	Sales Q/Q	-	Oper. Margin	-	RSI (14)	44.73	Volatility	7.06% 7.11%
Optionable	Yes	Debt/Eq	0.03	EPS Q/Q	44.60%	Profit Margin	-	Rel Volume	0.65	Prev Close	5.36
Shortable	Yes	LT Debt/Eq	0.03	Earnings	Mar 25 AMC	Payout	-	Avg Volume	141.58K	Price	5.50
Recom	1.70	SMA20	-3.81%	SMA50	-10.06%	SMA200	21.52%	Volume	92,075	Change	2.61%

Mar-01-21

Initiated

Northland Capital

Outperform

$10

Feb-03-20

Downgrade

Oppenheimer

Outperform → Perform

Apr-01-21 07:30AM	Eyenovia Announces Appointment of Renowned Ophthalmologist and Scientific Leader Dr. Julia Haller to its Board of Directors Business Wire
Mar-25-21 04:05PM	Eyenovia Reports Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire
02:30PM	Eyenovia, Inc. to Host Earnings Call ACCESSWIRE
Mar-23-21 07:30AM	Eyenovia and EVERSANA Announce Partnership to Support the Potential Launch and Commercialization of MydCombi for Mydriasis Business Wire
Mar-18-21 08:00AM	Eyenovia to Report Fourth Quarter and Full Year 2020 Results on Thursday, March 25 GlobeNewswire
Mar-17-21 08:00AM	Eyenovia Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and Safety of its MAP Fixed-Combination Tropicamide-Phenylephrine Product for Mydriasis Business Wire
Mar-10-21 08:00AM	Eyenovia to Participate in the 33rd Annual Roth Conference GlobeNewswire
Mar-08-21 12:24AM	Have Insiders Been Buying Eyenovia, Inc. (NASDAQ:EYEN) Shares This Year? Simply Wall St.
Mar-02-21 07:30AM	Eyenovia Announces FDA Acceptance of the MydCombi NDA Business Wire
Feb-16-21 08:00AM	Eyenovia to Host Key Opinion Leader Webinar on Presbyopia GlobeNewswire +6.16%
Jan-26-21 07:30AM	Eyenovia to Present at the Ophthalmology Innovation Summit (OIS) Presbyopia Innovation Showcase Business Wire
Jan-06-21 08:00AM	Eyenovia to Participate in Presbyopia Panel Discussion at the LifeSci Partners 10th Annual Corporate Access Event GlobeNewswire
Dec-29-20 07:00AM	Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually Business Wire
Dec-16-20 07:00AM	Eyenovia Announces First Patients Enrolled in Phase 3 Study of MicroLine for Presbyopia Business Wire
Dec-08-20 01:23AM	What Type Of Shareholders Own The Most Number of Eyenovia, Inc. (NASDAQ:EYEN) Shares? Simply Wall St.
Dec-03-20 07:00AM	Eyenovia Announces FDA Acceptance of IND for MicroLine for Presbyopia, Clearing Path to Initiate Phase 3 VISION Trial by Year End Business Wire
Dec-02-20 07:07PM	Is Eyenovia (EYEN) A Good Stock To Buy Now? Insider Monkey
Nov-10-20 04:06PM	Eyenovia Reports Third Quarter 2020 Financial Results GlobeNewswire
02:45PM	Eyenovia, Inc. to Host Earnings Call ACCESSWIRE
Nov-09-20 03:30PM	These 3 Penny Stocks Could Rally Over 100%, Says Roth Capital TipRanks
Nov-05-20 08:00AM	Eyenovia to Report Third Quarter 2020 Results on Tuesday, November 10 GlobeNewswire
Oct-13-20 03:40PM	Bausch Acquires License for Myopia Solution from Eyenovia Zacks
07:00AM	Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Total Potential License Payments and Development Cost Reimbursement and Savings of Approximately $100 Million GlobeNewswire
Oct-12-20 07:00AM	Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12 PR Newswire +5.60%
Oct-05-20 07:00AM	Eyenovia to Present Clinical Study Updates at the American Academy of Optometry Annual Meeting Business Wire
Sep-09-20 08:30AM	Eyenovia to Present at the 22nd Annual H.C. Wainwright Global Investment Conference GlobeNewswire
Aug-26-20 07:31AM	Stuart Grant Just Bought 9.0% More Shares In Eyenovia, Inc. (NASDAQ:EYEN) Simply Wall St.
Aug-24-20 08:30AM	Eyenovia, Inc. Announces Underwriters Full Exercise of Over-Allotment Option in Public Offering GlobeNewswire
Aug-21-20 04:05PM	Eyenovia, Inc. Announces Closing of Offering of Common Stock GlobeNewswire
Aug-19-20 09:10AM	Eyenovia, Inc. Prices Public Offering of Common Stock GlobeNewswire -16.70%
Aug-18-20 04:03PM	Eyenovia, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Aug-12-20 04:05PM	Eyenovia Reports Second Quarter 2020 Financial Results GlobeNewswire
07:29AM	The Daily Biotech Pulse: India Globalization Gets Nod For Alzheimer's Trial, Moderna's Vaccine Deal With US, Cellular Biomedicine To Go Private Benzinga
Aug-11-20 08:00AM	Eyenovia and Arctic Vision Announce Exclusive Collaboration and License Agreement to Develop and Commercialize MicroPine and MicroLine in Greater China and South Korea GlobeNewswire +38.19%
Jul-29-20 08:30AM	Eyenovia Announces Conference Call and Webcast for Second Quarter 2020 Financial Results GlobeNewswire
Jul-20-20 03:30PM	3 Strong Buy Healthcare Stocks Under $5 That Could Double (Or More) TipRanks +8.89%
Jun-30-20 04:05PM	Eyenovia Resumes Recruitment of Phase III CHAPERONE Study for Progressive Myopia GlobeNewswire
Jun-11-20 04:10PM	Eyenovia, Inc. Announces Adjournment of 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting Format GlobeNewswire
Jun-05-20 04:10PM	Eyenovia Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting Format GlobeNewswire
May-13-20 04:05PM	Eyenovia Reports First Quarter 2020 Financial Results GlobeNewswire -5.51%
May-06-20 08:30AM	Eyenovia Announces Conference Call and Webcast for First Quarter 2020 Financial Results GlobeNewswire
Apr-22-20 10:10AM	Will Eyenovia Continue to Surge Higher? Zacks
Mar-26-20 06:31AM	Insider Buying: Stuart Grant Just Spent US$1.9m On Eyenovia, Inc. (NASDAQ:EYEN) Shares Simply Wall St.
Mar-25-20 04:05PM	Eyenovia Reports Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire
02:30PM	Eyenovia, Inc. to Host Earnings Call ACCESSWIRE
Mar-24-20 05:10PM	Eyenovia, Inc. Announces Closing of Approximately $6.0 Million Private Placement GlobeNewswire +8.26%
Mar-23-20 06:35PM	Eyenovia, Inc. Announces Approximately $6.0 Million Private Placement GlobeNewswire
Mar-11-20 08:30AM	Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2019 Financial Results GlobeNewswire
Mar-04-20 08:30AM	Eyenovia to Participate in Two Upcoming Investor Conferences GlobeNewswire
Feb-17-20 07:33AM	How Does Eyenovia, Inc. (NASDAQ:EYEN) Affect Your Portfolio Volatility? Simply Wall St.
Feb-10-20 09:25AM	Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards? Zacks
Dec-19-19 09:55AM	Have Insiders Been Buying Eyenovia, Inc. (NASDAQ:EYEN) Shares? Simply Wall St. +12.39%
08:30AM	Eyenovia Expands Scientific Advisory Board with Two Experts in Optometry GlobeNewswire
Dec-02-19 09:02AM	Eyenovia, Inc. (EYEN) Shares March Higher, Can It Continue? Zacks -6.06%
Nov-27-19 09:00AM	All You Need to Know About Eyenovia, Inc. (EYEN) Rating Upgrade to Strong Buy Zacks +14.53%
Nov-13-19 04:05PM	Eyenovia Reports Third Quarter 2019 Financial Results GlobeNewswire +5.24%
Nov-12-19 10:42AM	Can European Buyouts Aid Canopy Growth's (CGC) Q2 Earnings? Zacks -7.29%
08:23AM	What's in Store for Applied Materials' (AMAT) Q4 Earnings? Zacks
Nov-11-19 11:24AM	Can Cannabis Therapy Drive Canopy Growth's (CGC) Q2 Earnings? Zacks
09:42AM	Overstock (OSTK) to Report Q3 Earnings: What's in Store? Zacks
07:50AM	5 Biotech Stocks Set to Beat Q3 Earnings Estimates Zacks
Nov-07-19 11:15AM	Cronos (CRON) to Report Q3 Earnings: What's in the Cards? Zacks
10:32AM	Tilray (TLRY) to Report Q3 Earnings: What's in the Cards? Zacks
Nov-06-19 09:56AM	Mettler-Toledo (MTD) to Post Q3 Earnings: What's in Store? Zacks +7.12%
Nov-05-19 11:50AM	CannTrust (CTST) to Report Q3 Earnings: What's in Store? Zacks
11:24AM	What's in Store for Cumberland Pharma (CPIX) in Q3 Earnings? Zacks
11:13AM	Zoetis (ZTS) to Report Q3 Earnings: What's in the Cards? Zacks
Nov-04-19 11:42AM	What's in the Cards for Zynerba (ZYNE) This Earnings Season? Zacks
10:56AM	EPAM Systems (EPAM) to Post Q3 Earnings: What's in Store? Zacks
10:49AM	TiVo (TIVO) to Report Q3 Earnings: What's in the Cards? Zacks
10:22AM	Expedia Group's (EXPE) to Post Q3 Earnings: What's in Store? Zacks
10:01AM	Factors to Consider Ahead of Cutera's (CUTR) Q3 Earnings Zacks
09:10AM	Factors Setting the Tone for Square's (SQ) Earnings in Q3 Zacks
Oct-31-19 10:47AM	Can Segmental Growth Aid Hologic (HOLX) in Q4 Earnings? Zacks
08:30AM	Eyenovia Announces Conference Call and Webcast for Third Quarter 2019 Financial Results GlobeNewswire
Oct-30-19 07:01AM	The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings Benzinga -7.32%
Oct-29-19 04:05PM	Eyenovia Advances MicroLine for the Treatment of Presbyopia Towards Phase III Development and Reprioritizes Late-Stage Ophthalmology Pipeline GlobeNewswire -5.63%
Oct-02-19 08:30AM	Eyenovia to Participate in Multiple Upcoming Medical Meetings GlobeNewswire
Sep-19-19 12:07PM	Do Insiders Own Lots Of Shares In Eyenovia, Inc. (NASDAQ:EYEN)? Simply Wall St.
Sep-03-19 08:30AM	Eyenovia to Present at Two Upcoming Investor Conferences GlobeNewswire
Aug-12-19 02:30PM	Eyenovia, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-19 08:30AM	Eyenovia Announces Conference Call and Webcast for Second Quarter 2019 Financial Results GlobeNewswire
Jul-16-19 04:05PM	Eyenovia, Inc. Announces Underwriters Full Exercise of Over-Allotment Option in Public Offering GlobeNewswire +10.74%
Jul-15-19 07:15PM	Eyenovia Inc (EYEN) CEO Tsontcho Ianchulev Bought $650,000 of Shares GuruFocus.com
04:30PM	Eyenovia, Inc. Announces Closing of Public Offering GlobeNewswire
Jul-11-19 11:13AM	Did Eyenovia, Inc. (NASDAQ:EYEN) Insiders Buy Up More Shares? Simply Wall St. -17.48%
09:00AM	Eyenovia, Inc. Prices Public Offering of Common Stock GlobeNewswire
Jul-10-19 04:07PM	Eyenovia, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire -14.17%
Jun-04-19 08:30AM	Eyenovia Enrolls First Patient in Phase III CHAPERONE Study for Progressive Myopia GlobeNewswire
May-14-19 06:30AM	Eyenovia Reports First Quarter 2019 Financial Results GlobeNewswire -15.11%
May-06-19 10:53AM	Introducing Eyenovia (NASDAQ:EYEN), The Stock That Dropped 33% In The Last Year Simply Wall St.
May-01-19 08:30AM	Eyenovia Announces Conference Call and Webcast for First Quarter 2019 Financial Results GlobeNewswire +5.35%
Mar-27-19 06:30AM	Eyenovia Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Mar-13-19 08:30AM	Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results GlobeNewswire
Mar-04-19 08:30AM	Eyenovia to Participate in Two Upcoming Investor Conferences GlobeNewswire
Feb-25-19 08:30AM	Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis GlobeNewswire +5.04%
Feb-13-19 08:30AM	Eyenovia confirms expanded MicroProst Phase III indication to enroll broad patient population for IOP lowering GlobeNewswire
Feb-06-19 08:30AM	Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia GlobeNewswire +13.64%
Feb-05-19 08:00AM	Biotech Stocks to Watch ACCESSWIRE +7.18%
Jan-31-19 08:30AM	Biotechs Investors Are Flocking To ACCESSWIRE +6.38%

Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print (MAP) platform technology. The company focuses on to develop clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. Its pipelines focus on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates in pipeline include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grant Stuart M.	10% Owner	Mar 05	Buy	5.50	35,000	192,500	4,254,748	Mar 08 05:34 PM
GANDOLFO JOHN P	Chief Financial Officer	Nov 19	Buy	3.40	4,000	13,600	6,000	Nov 23 04:05 PM
Grant Stuart M.	10% Owner	Oct 12	Buy	3.55	100,000	355,000	4,219,748	Oct 13 11:54 AM
Grant Stuart M.	10% Owner	Sep 24	Buy	2.99	75,000	224,500	4,119,748	Sep 25 01:42 PM
Clasby Jennifer G	VP, Clinical Operations	Sep 18	Option Exercise	1.95	26,737	52,137	55,702	Oct 16 05:04 PM
Grant Stuart M.	10% Owner	Aug 20	Buy	2.06	451,620	929,434	4,044,748	Aug 24 06:05 AM
Grant Stuart M.	10% Owner	Aug 19	Buy	3.60	333,000	1,198,800	3,593,128	Aug 24 06:05 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience